Capecitabine (X) improves quality of life (QoL) in patients (pts) with metastatic breast cancer (MBC).

被引：0
|
作者：
Segalla, J
Oliveira, C
Cabral, S
Lago, S
Ribeiro, R
Perdicaris, M
Abdo, E
Garicochea, B
Moore, F
Fabiani, C
机构：
[1] Fdn Amaral Carvalho, Jau Sao Paulo, Brazil
[2] Inst Brasileiro Controle Cancer, Sao Paulo, Brazil
[3] PUC, Hosp Sao Lucas, Porto Alegre, RS, Brazil
[4] Ctr Quimioterapia Antiblastica & Imunoterapia, Belo Horizonte, MG, Brazil
[5] Inst Canc Ceara, Fortaleza, Ceara, Brazil
[6] Beneficencia Portuguesa Santos, Santos, Brazil
[7] Hosp Perola Byngton, Sao Paulo, Brazil
[8] Fdn Benjamin Guimaraes, Belo Horizonte, MG, Brazil
[9] CEPON, Florianopolis, SC, Brazil
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2004年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S201 / S201
页数：1
相关论文
共 50 条
  • [1] Effect of capecitabine (X) on quality of life (QoL) in patients (pts) with metastatic breast cancer (MBC).
    Segalla, JGM
    Oliveira, CT
    Lago, S
    Cabral, S
    Ribeiro, R
    Perdicaris, M
    Abdo, E
    Garicochea, B
    Moore, FC
    Fabiani, C
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 761S - 761S
  • [2] Quality if life (QoL) improvements in patients (pts) with metastatic breast cancer (MBC) treated with capecitabine (X)
    Segalla, Jose
    Oliveira, Celia
    Lago, Sergio
    Cabral, Sebastiao
    Ribeiro, Ronaldo
    Perdicaris, Martha
    Abdo, E.
    Garicochea, B.
    Moore, F. C.
    Fabiani, C.
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 45 - 45
  • [3] Quality of life (QoL) improvements in patients (pts) with metastatic breast cancer (MBC) receiving capecitabine (X).
    Oliveira, C
    Beato, C
    Ribeiro, R
    Cabral, S
    Tessaro, S
    Lago, S
    Abdo, E
    Moura, G
    Perdicaris, M
    Garicochea, B
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 738S - 738S
  • [4] Capecitabine (X) improves quality of life (QoL) in patients (pts) with metastatic colorectal cancer (MCRC)
    Beato, Carlos
    Fedrico, M.
    Cabral, Sebastiao
    Durate, R.
    Van Eyll, B.
    Carvalho, M.
    Lago, Sergio
    Medeiros, E.
    Perdicaris, Martha
    MaChado, Denise
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 89 - 89
  • [5] Quality of life (QoL) improvements with capecitabine in patients with metastatic breast cancer (MBC)
    Segalla, J.
    Tosello, C.
    Ribeiro, R.
    Tessaro, S.
    Cabral, S.
    Perdicaris, M. R.
    Moura, G. L.
    Lago, S.
    Garicochea, B.
    Abdo, E.
    [J]. EJC SUPPLEMENTS, 2005, 3 (02): : 115 - 115
  • [6] Improvement in quality of life (QoL) and ECOG in a cohort of 1125 patients (pts) with metastatic breast cancer (MBC) treated with capecitabine (X)
    不详
    [J]. EJC SUPPLEMENTS, 2006, 4 (02): : 162 - 162
  • [7] Quality of life (QoL) improvements in 1464 patients (pts) with metastatic breast cancer (MBC) receiving capecitabine (X) in Brazil: Implications for oncology nurses
    Testa, C.
    Martins, F.
    GonAalves, D.
    Huttener, C.
    Aguiar, O.
    Oliveira, A.
    Pereira, C.
    Soffiatti, N.
    Ferro, R.
    Zamprogna, L.
    [J]. EUROPEAN JOURNAL OF ONCOLOGY NURSING, 2006, 10 (03) : 229 - 229
  • [8] Effects of capecitabine (X) an quality of life (QoL) in patients (pts) with metastatic colorectal cancer (MCRC).
    Beato, CAM
    Federico, MH
    Van Eyll, B
    Cabral, S
    Perdicaris, M
    Skare, NG
    Lago, S
    Carvalho, MP
    Moura, GL
    Duarte, RC
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 758S - 758S
  • [9] Evaluation of quality of life (QoL) in patients (pts) with metastatic colorectal cancer (MCRC) treated with capecitabine (X)
    Segalla, J
    van Eyll, B
    Federico, M
    Perdicaris, M
    Cabral, S
    Skare, N
    Saltz, E
    Moura, G
    Filho, U
    Franke, F
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 751S - 751S
  • [10] Capecitabine (X) in elderly patients (pts) with hormone-refractory metastatic breast cancer (MBC).
    Longo, F
    Magnolfi, E
    Borgomastro, A
    Gemma, D
    Salerno, M
    Ciorra, AA
    Traficante, D
    Di Seri, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 86S - 86S
12345